393 results on '"Tailleux, Anne"'
Search Results
52. Characterization of one anastomosis gastric bypass and impact of biliary and common limbs on bile acid and postprandial glucose metabolism in a minipig model
53. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
54. Plasma BCAA changes in Patients with NAFLD are Sex Dependent 1
55. The hepatic compensatory response to elevated systemic sulfide impairs medium chain fat oxidation and promotes diabetes
56. WED-458 - Increasing gut microbiota produced secondary bile acids to protect against non-alcoholic steatohepatitis
57. THU-244 - The intestinal immune barrier is associated with bile acid pool modifications in mice suffering from non-alcoholic steatohepatitis
58. Multiple Selection Criteria for Probiotic Strains with High Potential for Obesity Management
59. Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor
60. Inflammation‐induced cholestasis in cancer cachexia
61. Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production
62. Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice
63. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model
64. Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis
65. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
66. Alterations in bile acids and TGR5 activation in non-alcoholic steatohepatitis
67. Deletion of fibroblast activation protein provides atheroprotection
68. The hepatic compensatory response to elevated systemic sulfide promotes diabetes
69. Transcription profiling in the liver of undernourished male rat offspring reveals altered lipid metabolism pathways and predisposition to hepatic steatosis
70. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport
71. Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation
72. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model
73. PS1 - 2. Role of the tumour suppressor CDKN2A/p16INK4a in the development of perivascular adipose tissue
74. Deletion of fibroblast activation protein provides atheroprotection.
75. Inflammation‐induced cholestasis in cancer cachexia.
76. Tau deletion promotes brain insulin resistance
77. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD Short title: Bile acids in meta-inflammatory disorders
78. Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty
79. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase
80. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
81. Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics#
82. Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
83. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
84. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction
85. Diminution de l’Extraction Hépatique de l’Insuline Postprandiale après Chirurgie de Gastric Bypass
86. Rôle du récepteur nucléaire Farnésoid X (FXR) dans la réponse hypothalamique à l’insuline
87. Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention
88. Metabolic effects of bile acid sequestration
89. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1
90. The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
91. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways
92. p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages
93. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
94. Rapid and Body Weight–Independent Improvement of Endothelial and High-Density Lipoprotein Function After Roux-en-Y Gastric Bypass
95. CAD-29 - Rôle du récepteur nucléaire Farnésoid X (FXR) dans la réponse hypothalamique à l’insuline
96. CO-78 - Diminution de l’Extraction Hépatique de l’Insuline Postprandiale après Chirurgie de Gastric Bypass
97. Sox17 Regulates Liver Lipid Metabolism and Adaptation to Fasting
98. Impact of Endotoxin Challenge in Obese Pigs
99. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
100. O167 Pharmacological Sirt1 Activation In Apoe-/- Mice Provides Atheroprotection By Reducing Hepatic Pcsk9 Secretion And Enhancing Ldl-R Expression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.